Show simple item record

dc.contributor.authorAgrawal, Utkarsh
dc.contributor.authorKatikireddi, Srinivasa Vittal
dc.contributor.authorMcCowan, Colin
dc.contributor.authorMulholland, Rachel H.
dc.contributor.authorAzcoaga-Lorenzo, Amaya
dc.contributor.authorAmele, Sarah
dc.contributor.authorFagbamigbe, Adeniyi Francis
dc.contributor.authorVasileiou, Eleftheria
dc.contributor.authorGrange, Zoe
dc.contributor.authorShi, Ting
dc.contributor.authorKerr, Steven
dc.contributor.authorMoore, Emily
dc.contributor.authorMurray, Josephine L.K.
dc.contributor.authorShah, Syed Ahmar
dc.contributor.authorRitchie, Lewis
dc.contributor.authorO'Reilly, Dermot
dc.contributor.authorStock, Sarah J.
dc.contributor.authorBeggs, Jillian
dc.contributor.authorChuter, Antony
dc.contributor.authorTorabi, Fatemah
dc.contributor.authorAkbari, Ashley
dc.contributor.authorBedston, Stuart
dc.contributor.authorMcMenamin, Jim
dc.contributor.authorWood, Rachael
dc.contributor.authorTang, Ruby S.M.
dc.contributor.authorde Lusignan, Simon
dc.contributor.authorHobbs, F. D.Richard
dc.contributor.authorWoolhouse, Mark
dc.contributor.authorSimpson, Colin R.
dc.contributor.authorRobertson, Chris
dc.contributor.authorSheikh, Aziz
dc.date.accessioned2022-01-07T11:17:01Z
dc.date.available2022-01-07T11:17:01Z
dc.date.issued2021-12
dc.identifier.citationAgrawal , U , Katikireddi , S V , McCowan , C , Mulholland , R H , Azcoaga-Lorenzo , A , Amele , S , Fagbamigbe , A F , Vasileiou , E , Grange , Z , Shi , T , Kerr , S , Moore , E , Murray , J L K , Shah , S A , Ritchie , L , O'Reilly , D , Stock , S J , Beggs , J , Chuter , A , Torabi , F , Akbari , A , Bedston , S , McMenamin , J , Wood , R , Tang , R S M , de Lusignan , S , Hobbs , F D R , Woolhouse , M , Simpson , C R , Robertson , C & Sheikh , A 2021 , ' COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II) : a prospective cohort study ' , The Lancet Respiratory Medicine , vol. 9 , no. 12 , pp. 1439-1449 . https://doi.org/10.1016/S2213-2600(21)00380-5en
dc.identifier.issn2213-2600
dc.identifier.otherPURE: 211303143
dc.identifier.otherPURE UUID: 58a9b15a-5ef2-4b3a-9036-7d12f5c1c87a
dc.identifier.otherScopus: 85119139431
dc.identifier.otherPubMed: 34599903
dc.identifier.urihttps://hdl.handle.net/2164/17801
dc.descriptionFunding Information: AS, JM, and CR are members of the Scottish Government Chief Medical Officer's COVID-19 Advisory Group. JM is a member of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) and AS is a member of the NERVTAG Risk Stratification Subgroup and an unfunded member of Astra-Zeneca's COVID-19 Strategic Consultancy Group: Thrombocytopenia Taskforce. JM is a member of the Scientific Advisory Group on Emergencies (SAGE) and chairs the COVID Scottish National Incident Management Team and the Scientific Committee of the European Centre for Disease Prevention and Control/WHO-funded IMOVE-COVID-19 group. CM reports research funding from Medical Research Council (MRC), Health Data Research UK, National Institute for Health Research (NIHR), and Scottish Chief Scientist Office (CSO). SJS reports research funding from Wellcome Trust, MRC, NIHR, and Scottish CSO. CRS declares funding from the MRC, NIHR, Scottish CSO, and the New Zealand Ministry for Business, Innovation and Employment and Health Research Council during the conduct of this study. SVK is co-chair of the Scottish Government's Expert Reference Group on COVID-19 and ethnicity, is a member of the SAGE subgroup on ethnicity, and acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship, MRC, and Scottish CSO. CR is a member of the Scientific Pandemic Influenza Group on Modelling and the Medicines and Healthcare Products Regulatory Agency Vaccine Benefit and Risk Working Group. JLKM is a member of the COVID Scottish National Incident Management Team. SdL has received funding through his University from AstraZeneca. FDRH acknowledges part support from the NIHR Applied Research Collaboration Oxford Thames Valley and the NIHR Oxford University Hospital Biomedical Research Centre. All other authors declare no competing interests. Funding Information: EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE?The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government Director-General Health and Social Care. We thank Dave Kelly from Albasoft for his support with making primary care data available and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, Laura Gonzalez Rienda, Pam McVeigh, Amanda Burridge, Sumedha Asnani-Chetal, and Afshin Dastafshan for their support with project management and administration. We acknowledge the support of the EAVE II Patient Advisory Group. UA, CM, AA-L, and AFF acknowledge funding from Chief Scientist Office Rapid Research in COVID-19 programme (COV/SAN/20/06) and Health Data Research UK (measuring and understanding multimorbidity using routine data in the UK?HDR-9006; CFC0110). SVK acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government's Chief Scientist Office (SPHSU17). SJS is funded by a Wellcome Trust Clinical Career Development Fellowship (209560/Z/17/Z). Funding Information: EAVE II is funded by the Medical Research Council (MR/R008345/1) with the support of BREATHE—The Health Data Research Hub for Respiratory Health [MC_PC_19004], which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government Director-General Health and Social Care. We thank Dave Kelly from Albasoft for his support with making primary care data available and James Pickett, Wendy Inglis-Humphrey, Vicky Hammersley, Maria Georgiou, Laura Gonzalez Rienda, Pam McVeigh, Amanda Burridge, Sumedha Asnani-Chetal, and Afshin Dastafshan for their support with project management and administration. We acknowledge the support of the EAVE II Patient Advisory Group. UA, CM, AA-L, and AFF acknowledge funding from Chief Scientist Office Rapid Research in COVID-19 programme (COV/SAN/20/06) and Health Data Research UK (measuring and understanding multimorbidity using routine data in the UK—HDR-9006; CFC0110). SVK acknowledges funding from a NHS Research Scotland Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2), and the Scottish Government's Chief Scientist Office (SPHSU17). SJS is funded by a Wellcome Trust Clinical Career Development Fellowship (209560/Z/17/Z).en
dc.format.extent11
dc.language.isoeng
dc.relation.ispartofThe Lancet Respiratory Medicineen
dc.rightsUnder a Creative Commons license https://creativecommons.org/licenses/by/4.0/en
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectSDG 9 - Industry, Innovation, and Infrastructureen
dc.subjectR Medicineen
dc.subjectPulmonary and Respiratory Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subjectMR/R008345/1en
dc.subjectMC_UU_00022/2en
dc.subjectChief Scientist Office (CSO)en
dc.subjectCOV/SAN/20/06en
dc.subjectSPHSU17en
dc.subjectWellcome Trusten
dc.subject209560/Z/17/Zen
dc.subject.lccRen
dc.titleCOVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II) : a prospective cohort studyen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1016/S2213-2600(21)00380-5
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85119139431&partnerID=8YFLogxKen
dc.identifier.vol9en
dc.identifier.iss12en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record